Medicare expected to negotiate obesity drug prices soon, new analysis predicts

By STAT News
| March 21, 2024

Medicare will likely choose the obesity drug semaglutide for price negotiation 'within the next few years,' according to a new analysis from nonpartisan congressional budget experts.

Full story

#1

Recent research on Paxlovid shows there is "solid data on its effectiveness," a co-author of the study told HealthLeaders. ...

A new personal protective equipment manufacturing company is set to open in Cincinnati next year. ...